EMAIL THIS PAGE TO A FRIEND

Antimicrobial agents and chemotherapy

Use of xylitol to enhance the therapeutic efficacy of polymethylmethacrylate-based antibiotic therapy in treatment of chronic osteomyelitis.


PMID 22948866

Abstract

Using a rabbit model of postsurgical osteomyelitis, we demonstrate that incorporation of xylitol into polymethylmethacrylate (PMMA) bone cement enhances the elution of daptomycin under in vivo conditions. We also demonstrate that this can be correlated with an improved therapeutic outcome in the treatment of a chronic bone infection following surgical debridement.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

PHR1280
Xylitol, Pharmaceutical Secondary Standard; Certified Reference Material
C5H12O5